Logo image of MAGN

MAGNERA CORP (MAGN) Stock Fundamental Analysis

USA - NYSE:MAGN - US55939A1079 - Common Stock

10.8825 USD
-0.16 (-1.43%)
Last: 9/15/2025, 10:15:53 AM
Fundamental Rating

3

Overall MAGN gets a fundamental rating of 3 out of 10. We evaluated MAGN against 9 industry peers in the Paper & Forest Products industry. MAGN has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, MAGN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

MAGN had negative earnings in the past year.
In the past year MAGN has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: MAGN reported negative net income in multiple years.
In multiple years MAGN reported negative operating cash flow during the last 5 years.
MAGN Yearly Net Income VS EBIT VS OCF VS FCFMAGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

1.2 Ratios

The Return On Assets of MAGN (-3.26%) is comparable to the rest of the industry.
MAGN has a worse Return On Equity (-11.87%) than 66.67% of its industry peers.
With a decent Return On Invested Capital value of 1.50%, MAGN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MAGN is below the industry average of 5.72%.
The 3 year average ROIC (1.29%) for MAGN is below the current ROIC(1.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -3.26%
ROE -11.87%
ROIC 1.5%
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
MAGN Yearly ROA, ROE, ROICMAGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

MAGN's Operating Margin of 2.48% is fine compared to the rest of the industry. MAGN outperforms 66.67% of its industry peers.
In the last couple of years the Operating Margin of MAGN has declined.
MAGN has a Gross Margin (10.55%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MAGN has declined.
Industry RankSector Rank
OM 2.48%
PM (TTM) N/A
GM 10.55%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
MAGN Yearly Profit, Operating, Gross MarginsMAGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MAGN is destroying value.
MAGN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MAGN has been reduced compared to 5 years ago.
The debt/assets ratio for MAGN is higher compared to a year ago.
MAGN Yearly Shares OutstandingMAGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MAGN Yearly Total Debt VS Total AssetsMAGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.01, we must say that MAGN is in the distress zone and has some risk of bankruptcy.
MAGN's Altman-Z score of 1.01 is on the low side compared to the rest of the industry. MAGN is outperformed by 88.89% of its industry peers.
MAGN has a Debt/Equity ratio of 1.76. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.76, MAGN is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF N/A
Altman-Z 1.01
ROIC/WACC0.2
WACC7.56%
MAGN Yearly LT Debt VS Equity VS FCFMAGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

MAGN has a Current Ratio of 2.54. This indicates that MAGN is financially healthy and has no problem in meeting its short term obligations.
MAGN has a Current ratio (2.54) which is in line with its industry peers.
A Quick Ratio of 1.63 indicates that MAGN should not have too much problems paying its short term obligations.
The Quick ratio of MAGN (1.63) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 1.63
MAGN Yearly Current Assets VS Current LiabilitesMAGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for MAGN have decreased strongly by -93.18% in the last year.
Looking at the last year, MAGN shows a decrease in Revenue. The Revenue has decreased by -7.09% in the last year.
The Revenue has been growing by 9.85% on average over the past years. This is quite good.
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-7.09%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%152.63%

3.2 Future

MAGN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.60% yearly.
MAGN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.34% yearly.
EPS Next Y-14%
EPS Next 2Y16.28%
EPS Next 3Y41.51%
EPS Next 5Y36.6%
Revenue Next Year120.68%
Revenue Next 2Y41.92%
Revenue Next 3Y28.37%
Revenue Next 5Y21.34%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MAGN Yearly Revenue VS EstimatesMAGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
MAGN Yearly EPS VS EstimatesMAGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15 20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MAGN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MAGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAGN Price Earnings VS Forward Price EarningsMAGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

MAGN's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.21
MAGN Per share dataMAGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

MAGN's earnings are expected to grow with 41.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.28%
EPS Next 3Y41.51%

More info and screens

0

5. Dividend

5.1 Amount

MAGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAGNERA CORP

NYSE:MAGN (9/15/2025, 10:15:53 AM)

10.8825

-0.16 (-1.43%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)01-07 2026-01-07
Inst Owners91.33%
Inst Owner Change13.43%
Ins Owners0.54%
Ins Owner Change19.9%
Market Cap387.42M
Analysts45.71
Price Target14.28 (31.22%)
Short Float %11.21%
Short Ratio4.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.23%
Min Revenue beat(2)-4.4%
Max Revenue beat(2)-4.06%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.34
P/tB 2
EV/EBITDA 8.21
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-2.39
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS75.76
BVpS31.77
TBVpS5.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.26%
ROE -11.87%
ROCE 1.9%
ROIC 1.5%
ROICexc 1.63%
ROICexgc 2.29%
OM 2.48%
PM (TTM) N/A
GM 10.55%
FCFM N/A
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
ROICexc(3y)1.4%
ROICexc(5y)2.53%
ROICexgc(3y)1.77%
ROICexgc(5y)3.33%
ROCE(3y)1.65%
ROCE(5y)2.9%
ROICexcg growth 3Y-33.98%
ROICexcg growth 5Y-5.57%
ROICexc growth 3Y-31.54%
ROICexc growth 5Y-3.54%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF N/A
Debt/EBITDA 7.73
Cap/Depr 28.75%
Cap/Sales 2.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.54
Quick Ratio 1.63
Altman-Z 1.01
F-Score4
WACC7.56%
ROIC/WACC0.2
Cap/Depr(3y)52.93%
Cap/Depr(5y)52.63%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-14%
EPS Next 2Y16.28%
EPS Next 3Y41.51%
EPS Next 5Y36.6%
Revenue 1Y (TTM)-7.09%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%152.63%
Revenue Next Year120.68%
Revenue Next 2Y41.92%
Revenue Next 3Y28.37%
Revenue Next 5Y21.34%
EBIT growth 1Y117.08%
EBIT growth 3Y-25.3%
EBIT growth 5Y1.43%
EBIT Next Year515.25%
EBIT Next 3Y86.31%
EBIT Next 5Y61.31%
FCF growth 1Y-62.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-177.22%
OCF growth 3YN/A
OCF growth 5YN/A